Karasick Matthew 4
4 · LiveRamp Holdings, Inc. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
LiveRamp (RAMP) CPO Matthew Karasick Receives RSU Award
What Happened
- Matthew Karasick, Chief Product Officer of LiveRamp Holdings, was granted 38,961 restricted stock units (RSUs) on May 15, 2026. The RSUs have no purchase price (reported at $0) and represent a contingent right to receive one share of common stock per RSU upon vesting. This is an award grant (not a purchase or sale) and does not by itself indicate buying or selling activity.
Key Details
- Transaction date: May 15, 2026; Form 4 filed May 19, 2026 (filed 4 days after the transaction).
- Grant size: 38,961 RSUs; reported acquisition price: $0.00.
- Shares owned after the transaction: not specified in the filing.
- Footnote (F1): RSUs granted under the 2005 Equity Compensation Plan. Vesting: 1/3 vests on May 22, 2027; remaining shares vest in equal quarterly installments on the 22nd of each applicable month thereafter until fully vested, subject to continued employment.
- Transaction type code: A = Award/Grant.
Context
- RSUs are compensation awards that convert to shares upon vesting; they are commonly used to retain executives and align incentives with shareholders. Because this is a grant (not a market purchase), it should be viewed as part of executive compensation rather than an immediate bullish market signal.
- The filing occurred four days after the transaction date; Form 4s are generally required within two business days of the transaction, so investors may note the delayed filing.
Insider Transaction Report
Form 4
Karasick Matthew
CHIEF PRODUCT OFFICER
Transactions
- Award
COMMON STOCK, $.10 PAR VALUE
[F1]2026-05-15+38,961→ 129,440 total
Footnotes (1)
- [F1]These restricted stock units ("RSUs") are granted pursuant to the registrant's 2005 Equity Compensation Plan. Each RSU represents a contingent right to receive one share of the registrant's common stock. Vesting will take place over three years from the date of grant, with 1/3 of the shares scheduled to vest on May 22, 2027, and the remainder vesting in equal quarterly amounts thereafter on the 22nd day of the applicable month until 100% vested, contingent upon the recipient's continued employment with the registrant.
Signature
/s/ BY: JERRY C. JONES, ATTORNEY-IN-FACT FOR: MATTHEW KARASICK|2026-05-19